2m 2m 2m 2m 2m 2m 2m
PMGC HLDG (ELAB)
NASDAQ
$2.72+$0.06 (+2.26%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.3MMarket Cap
- -99.82%1-Year Change
- BiotechnologyIndustry
PMGC HLDG (ELAB)
$2.72+$0.06 (+2.26%)
ELAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.66 | ||
Change | -$0.12 (-4.32%) | ||
Open | $2.69 | ||
High | $2.77 | ||
Low | $2.62 | ||
Previous Close | $2.78 | ||
Volume | 5,179 | ||
30-Day Average Volume | 42,155 | ||
1-Week Change | -12.50% | ||
1-Month Change | -37.56% | ||
1-Year Change | -99.82% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 809,579 | ||
Total Assets | $36.6M | ||
Market Cap | $2.3M | ||
Enterprise Value | -$6.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.3M | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.6M | ||
Net Working Capital | $5.5M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -5 | ||
P/B | 0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/21/2026 | ||
Earnings & Revenue